Login

Alan Beasley, CEO, Hydroponics Company Ltd 00:00:00

Share On Facebook Share On Twitter

OnMarket IPO: The Hydroponics Company (ASX:THC) interview with Alan Beasley & Andrew Beehag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Market Turbulence: Insights from Emin Baghramyan on Low Volatility Investing | Lead Portfolio Manager, TD Asset Management
00:10:00
Unlocking Steelport Drift: Advancing One of the World's Premier Vanadium Projects in South Africa
00:10:00
Joining the ESG Data Convergence Initiative: Insights and Impact
00:10:00
Nahid Jetha on Portfolio Tail Risk Management: Essential Strategies for Modern Investing | Nahid Jetha - CEO of QTS Capital Management LLC
00:10:00
"Unveiling Litigation Finance: Cesar Bello's Insights on Investment Strategies and Risk Management at Corbin Capital Partners"
00:10:00
Romeo's Gold Resources: Exploring BC's Golden Triangle
00:10:00
Culture Rooted in Social Capital Drives Long-Term Success
00:10:00
Comprehensive, Fee-Only Financial Planning Tailored for You
00:10:00
Bradda Head Lithium CEO Discusses Strategic U.S. Expansion and Promising Drilling Results
00:10:00
Financial Planning 101 for Physicians: A Comprehensive Guide by Matt Elliott, CFP | Matt Elliott - CERTIFIED FINANCIAL PLANNER, professional and founder of Pulse Financial Planning.
00:10:00
Addressing Structural Racism in Healthcare through Innovative Technology Solutions | Andrew Toy, CEO, Clover Health Investments Corp.
00:10:00
AEM Holdings' 2020 Singapore Business Awards nomination | Chandran Nair, CEO, Aem Holdings Ltd AWX:SES

© 2017 - Neuhu+